Account
Insider Insights
27.07.2022
Macmillan alliance will provide digital health app

According to Big health, randomised controlled trials have shown that 71% of patients who used Dayli...

Read more
Insider Insights
27.07.2022
AmerisourceBergen aims to make access to digital

The new system – called DTx Connect – aims to help doctors order both prescription and non-presc...

Read more
Insider Insights
19.07.2022
NICE provides detail on Early Value Assessment

NICE provided more detail into how the process will work, with the early value assessments providing...

Read more
Insider Insights
14.07.2022
HRA pharma bids to bring first OTC contraceptive p

Access to birth control is more important than ever after Roe v Wade was struck down, amid reports t...

Read more
Insider Insights
13.07.2022
Big pharmas lose out in Chinas latest round of dru

AZ has warned its China revenues will decline mid-single-digit percentage in 2022 after years of dou...

Read more
Insider Insights
13.07.2022
NICE expands access of Tremfya in England and Wale

The HTA initially recommended Tremfya as a treatment option for adults with active psoriatic arthrit...

Read more
Insider Insights
11.07.2022
New pharmaceutical updated cost containment measur

This updated bill contains some similar measures to those proposed in March as well as some addition...

Read more
Insider Insights
27.06.2022
Health innovation plan

France’s Health Innovation Plan 2030, announced by President Emmanuel Macron back in June 2021, wi...

Read more
Insider Insights
27.06.2022
EURORDIS release joint statement on patient access

They came up with six proposals, split into three subgroups, aimed at addressing the key barriers to...

Read more
Insider Insights
23.06.2022
NICE publish their new real world evidence framewo

NICE have been clear that this framework should not be interpreted as minimum standards for real-wor...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.